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Summary 
A 52-year-old man without underlying diseases visited the local hospital with 
symptoms of memory deficit and mild headache. Radiological examination of the brain 
with computed tomography (CT) revealed hydrocephalus. Etiology was not revealed by 
cerebrospinal fluid (CSF) analysis, and a ventricular-atrial (V-A) shunt was installed. 
The patient had congestion and dacryorrhea of the right eye and diagnosed uveitis three 
months after placement of the V-A shunt. The serum cryptococcal antigen (CrAg) tested 
positive at a titration of 64 times. Additionally, the right eye anterior chamber aqueous 
humor (ACAH), cerebrospinal fluid (CSF) and prostate fluid were positive for 
Cryptococcus antigen at a titration of 128 times; and Cryptococcus neoformans var. 
grubii was isolated from the peripheral blood, CSF and ACAH, resulting in a diagnosis 
of disseminated cryptococcosis. Fluconazole (FLCZ) at 800 mg/day was administered 
for the first two days, followed by a 400 mg /day maintenance dose. After six months of 
treatment, his visual power recovered. This is a rare disseminated cryptococcosis with 
uveitis case, successfully treated by FLCZ. Disseminated cryptococcosis should be 
considered in cases with mild symptoms, and V-A shunt installation for hydrocephalus.  
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Introduction 
Cryptococcus neoformans can infect not only HIV-positive patients and 
non-HIV-infected immunocompromised patients, but also apparently immunocompetent 
patients. Cryptococcal infection is a common deep mycosis, and 10% of all pulmonary 
cryptococcus infections cause non-symptomatic meningoencephalitis. Cryptococcal 
endophthalmitis in non-immunosuppressed patients is rare, and the visual disturbance 
frequently causes a loss of visual power. We succeeded in treating a patient with 
disseminated cryptococcosis with severe endophthalmitis by using a loading dose of 
fluconazole (FLCZ) and flucytosine (5-FC).  
 
Case Report 
  A 52-year-old man, who was a roofer and had previously been healthy, visited the 
local hospital in July 2003 complaining of memory deficit and mild headache. 
Radiological examination by brain CT revealed an enlargement of the lateral ventricle. 
The analysis of cerebrospinal fluid (CSF) including appearance, cell counts and 
measurement of total protein and glucose showed no abnormality, but there was an 
increased opening pressure of 210 mm H2O. The etiology of hydrocephalus, such as 
bacteria, tuberculosis, viral infection, and malignant diseases were excluded by culture, 
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PCR, and antibody test.  
  Although the definite etiology was not known, corticosteroids were administered, but 
the results were ineffective. Neurosurgical intervention, with a ventricular-peritoneal 
shunt (V-P shunt), was then performed to relieve the hydrocephalus. Symptoms and 
CSF pressure improved soon afterward. Three months later, the patient’s symptoms 
re-appeared due to decreased function of the shunt. The V-P shunt was replaced with a 
Ventricular-atrial shunt (V-A shunt).  
  Three months after installation of the V-A shunt, the patient had congestion and 
dacryorrhea of the right eye. He was diagnosed with uveitis by an ophthalmologist. A 
fundus examination revealed bilateral multiple white spots on the fundus oculi, with 
more serious findings in the right eye (Figure 1). His visual acuity in the right eye was 
20/500, and in the left eye, it was 20/10. He was treated with dexamethasone injected 
directly into the subconjunctival space for seven days; however, the lesion enlarged. 
Intraocular hemorrhage occurred in the white spots and vitreous opacities were 
observed, and the patient’s eyesight declined significantly. An infectious uveitis was 
expected because of the rapid exacerbation.  
The patient was referred to the infectious diseases department for further 
management, and to confirm the diagnosis. On admission, laboratory findings showed a 
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slightly elevated serum concentration of C-reactive protein (CRP) and a high 
erythrocyte sedimentation rate. The patient’s immune status was normal. A tuberculin 
skin test was positive, and the responses of peripheral blood T cells to mitogens were 
normal. Although eosinophilic cryptococcal meningoencephalitis has been shown to 
occur especially in patients with hematological malignancies, no eosinphilia was 
observed in our case [1]. Cryptococcal infection was suspected because of the patient’s 
history of hydrocephalus of unknown origin, with no symptoms other than memory 
deficit. The serum cryptococcal antigen (CrAg) test was positive at a titration of 64 
times. Additionally, the right eye anterior chamber aqueous humor (ACAH), CSF, and 
prostate fluid were positive for Cryptococcus antigen at a titration of 128 times. 
Yeast-like cells with a thick capsule were observed with India ink stain in both the 
ACAH and CSF. Cryptococcus neoformans var. grubii (the serotype was determined by 
using a Crypto Check serotyping kit from Iatron Laboratories, Tokyo, Japan) was 
isolated on Sabouraud dextrose agar from the patient’s peripheral blood, CSF and 
ACAH, resulting in the diagnosis of disseminated cryptococcosis. A drug susceptibility 
test was performed according to the M27-A2 protocol of CLSI [2], and the minimum 
inhibitory concentrations (MICs) were as follows: amphotericin-B (AMPH-B) 
0.5μg/ml; fluconazole (FLCZ) 2μg/ml; itraconazole 0.125μg/ml; flucytosine (5-FC) 
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4.0μg/ml. It was reported that the antifungal drug susceptibility to C. neoformans was 
determined as follows [3]: FLCZ: SDD (susceptible-Dose Dependent) 2-8μg/ml; 5-FC: 
S 2-8μg/ml. FLCZ and 5-FC had good susceptibility in our case. 
As a roofer, he had opportunities to come in contact with pigeons’ nests. 
C.neoformans is often found in soil enriched with bird droppings. The patient’s immune 
status and general status were normal. We administered FLCZ at 800 mg/day for the 
first two days, followed by a 400 mg /day maintenance dose. FLCZ trough levels were 
33.5 μg/ml and 15.8 μg/ml in the ACAH and serum respectively, which indicated 
excellent FLCZ penetration to the eye tissue. The patient’s visual acuity gradually 
improved, but the vitreous opacities remained, so we added oral 5-FC (6 g/day) 29 days 
after the initiation of FLCZ.   
His eyesight returned to 20/30 after thirty days of FLCZ treatment, which is what it 
was before the illness began. The cryptococcus antigen levels in the serum, ACAH, and 
CSF decreased to ×16, ×64, and ×8, respectively. Bilateral multiple white spots on the 
fundus oculi almost resolved 6 months after antifungal treatment. Since the pathogen 
was not detected in the India ink stain and was not isolated by culture 6 months after 
initiation of treatment (Cryptococcus antigen levels in CSF maintained ×2), antifungal 
agents were discontinued and no recurrence was observed. 
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 Discussion 
Deep seated fungal infections caused by Candida spp., Aspergillus spp. and C. 
neoformans are on the rise despite recent medical advances. C. neoformans is 
recognized as the third most common fungal pathogen in autopsied cases in Japan, and 
is a worldwide, ubiquitous fungus found particularly in soil contaminated by pigeon or 
chicken droppings. In particular, cryptococcal infection occurs not only in 
immunocompromised patients such as those with AIDS, transplant recipients, or 
hematological malignancies and those receiving corticosteroids, but also in healthy 
individuals. Cryptococcal meningoencephalitis is the most common life-threatening, 
opportunistic fungal meningitis. Despite the advent of new antifungal drugs and modern 
imaging techniques, mortality and morbidity rates of cryptcoccal meningoencephalitis 
remain high. Hydrocephalus is an occasional complication of cryptococcal 
meningoencephalitis. Delays in the diagnosis and treatment of hydrocephalus are 
directly related to poor outcome, including various degrees of residual neurological 
sequelae [4]. In addition, cryptococcal endophthalmitis is rare [4]. According to a 
review from Crump et al [5], only 27 cases have been reported over the last 23 years, 
and almost half of these had no underlying diseases. Only six (27%) out of 22 patients 
with central nervous system (CNS) involvement had ocular lesions before developing 
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symptomatic meningitis. Cryptococcal endophthalmitis frequently results in severe 
visual loss, and return of normal vision following treatment is uncommon. 
In this case, cryptococcal meningitis might have existed prior to installation of the 
V-A shunt although an antigen test of CSF was not performed, and the shunt might be 
the major cause of disseminated cryptococcosis, including uveitis. Early shunt 
replacement for hydrocephalus is recommended to avoid irreversible neurological 
complications [6]. Tang also reported the efficacy of the V-A shunt for cryptococcal 
meningitis, and an active stage of cryptococcal meningitis does not contraindicate the 
necessity of shunting. Premedication with antifungal drugs is unnecessary [7]. There are 
eight reports regarding cryptococcal ventricular shunt infection [8-12]. Seven of the 
eight cases had clinical syndromes consistent with reactivation of an endogenous 
infection between 10 days and 12 months after placement of the shunt. Although 
treatment regimens included AMPH-B and 5-FC in all cases, cryptococcal shunt 
infection had poor outcomes; four of the eight patients died.   
In our case, we administered FLCZ because clinical symptoms were mild, there was 
evidence of effectiveness for the treatment of cryptococcal meningitis [13,14], there was 
good penetration into the CNS and eye tissue [15,16,], and it is less toxic than AMPH-B. 
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This resulted in better compliance for long-term usage of FLCZ. We successfully treated 
disseminated cryptococcosis, including uveitis, with this drug.  
Recently, fungal infections and formation of biofilms affecting intravascular devices 
are well known, particularly Candida species. C. neoformans is also reported to form 
biofilm on polystyrene plates [17] and prosthetic medical devices, including 
ventriculoatrial shunt catheters [8]. Biofilm formation is associated with persistent 
infection, since biofilm increases resistance against host immune systems and 
antimicrobial or antifungal therapy by constituting a physical barrier, so it could be 
correlated with poor outcome. Martinez et al investigated the efficacy of antifungal 
agents to cryptococcus biofilm in vitro, and reported that C. neoformans cells and 
preformed biofilm were susceptible to AMPH-B and caspofungin [18]. In our case, the 
possibility that biofilm formed in the V-A shunt is less likely since no recurrence was 
confirmed after discontinuation of treatment, and without removing the V-A shunt.  
In conclusion, cryptococcal meningitis often progresses slowly and gradually, with 
mild symptoms [19], compared with meningoencephalitis due to other pathogens, such 
as herpes virus, bacteria or tuberculosis. Delayed diagnosis and initiation of treatment 
often result in disseminated disease and poor outcome. When we evaluate patients with 
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hydrocephalus and mild, slowly progressing symptoms, we should consider the 
possibility of cryptococcal meningitis and perform the cryptococcal antigen test. In 
addition, shunt-induced, disseminated cryptococcal infection should also be considered 
when a V-A shunt is installed in the patient with cryptococcal meningitis. 
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Multiple white spots are shown in the right ocular fundus.  
 
